Literature DB >> 19118373

Paroxysmal nocturnal hemoglobinuria and myelodysplastic syndromes: clonal expansion of PIG-A-mutant hematopoietic cells in bone marrow failure.

Neal S Young1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19118373      PMCID： PMC2625409          DOI： 10.3324/haematol.2008.001297

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  24 in total

1.  Cytogenetic abnormalities in paroxysmal nocturnal haemoglobinuria usually occur in haematopoietic cells that are glycosylphosphatidylinositol-anchored protein (GPI-AP) positive.

Authors:  Elaine M Sloand; Monika Fuhrer; Keyvan Keyvanfar; Lori Mainwaring; Jaroslaw Maciejewski; Yu Wang; Sarah Johnson; A John Barrett; Neal S Young
Journal:  Br J Haematol       Date:  2003-10       Impact factor: 6.998

2.  Relationship between bone marrow failure syndromes and the presence of glycophosphatidyl inositol-anchored protein-deficient clones.

Authors:  J P Maciejewski; C Rivera; H Kook; D Dunn; N S Young
Journal:  Br J Haematol       Date:  2001-12       Impact factor: 6.998

Review 3.  Paroxysmal nocturnal hemoglobinuria as a molecular disease.

Authors:  W F Rosse
Journal:  Medicine (Baltimore)       Date:  1997-03       Impact factor: 1.889

4.  Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes.

Authors:  D E Dunn; P Tanawattanacharoen; P Boccuni; S Nagakura; S W Green; M R Kirby; M S Kumar; S Rosenfeld; N S Young
Journal:  Ann Intern Med       Date:  1999-09-21       Impact factor: 25.391

Review 5.  Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?

Authors:  J Barrett; Y Saunthararajah; J Molldrem
Journal:  Semin Hematol       Date:  2000-01       Impact factor: 3.851

6.  Differential gene expression in hematopoietic progenitors from paroxysmal nocturnal hemoglobinuria patients reveals an apoptosis/immune response in 'normal' phenotype cells.

Authors:  G Chen; W Zeng; J P Maciejewski; K Kcyvanfar; E M Billings; N S Young
Journal:  Leukemia       Date:  2005-05       Impact factor: 11.528

7.  Paroxysmal nocturnal haemoglobinuria clones in patients with myelodysplastic syndromes.

Authors:  M Iwanaga; K Furukawa; T Amenomori; H Mori; H Nakamura; K Fuchigami; S Kamihira; H Nakakuma; M Tomonaga
Journal:  Br J Haematol       Date:  1998-07       Impact factor: 6.998

8.  Myelodysplasia in a patient with pre-existing paroxysmal nocturnal haemoglobinuria: a clonal disease originating from within a clonal disease.

Authors:  L Longo; M Bessler; P Beris; D Swirsky; L Luzzatto
Journal:  Br J Haematol       Date:  1994-06       Impact factor: 6.998

9.  Clinical significance of a minor population of paroxysmal nocturnal hemoglobinuria-type cells in bone marrow failure syndrome.

Authors:  Hongbo Wang; Tatsuya Chuhjo; Shizuka Yasue; Mitsuhiro Omine; Shinji Nakao
Journal:  Blood       Date:  2002-08-08       Impact factor: 22.113

10.  Detection of paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes and related bone marrow diseases, with emphasis on diagnostic pitfalls and caveats.

Authors:  Sa A Wang; Olga Pozdnyakova; Jeffrey L Jorgensen; L Jeffrey Medeiros; Dariusz Stachurski; Mary Anderson; Azra Raza; Bruce A Woda
Journal:  Haematologica       Date:  2008-11-10       Impact factor: 9.941
View more
  9 in total

Review 1.  Anemia of Central Origin.

Authors:  Kazusa Ishii; Neal S Young
Journal:  Semin Hematol       Date:  2015-07-09       Impact factor: 3.851

2.  Blood consult: paroxysmal nocturnal hemoglobinuria and its complications.

Authors:  Danielle M Townsley; Neal S Young
Journal:  Blood       Date:  2013-09-10       Impact factor: 22.113

3.  CRISPR/Cas9 PIG -A gene editing in nonhuman primate model demonstrates no intrinsic clonal expansion of PNH HSPCs.

Authors:  Tae-Hoon Shin; Eun Jung Baek; Marcus A F Corat; Shirley Chen; Jean-Yves Metais; Aisha A AlJanahi; Yifan Zhou; Robert E Donahue; Kyung-Rok Yu; Cynthia E Dunbar
Journal:  Blood       Date:  2019-04-19       Impact factor: 22.113

4.  Paroxysmal nocturnal hemoglobinuria clones in severe aplastic anemia patients treated with horse anti-thymocyte globulin plus cyclosporine.

Authors:  Phillip Scheinberg; Michael Marte; Olga Nunez; Neal S Young
Journal:  Haematologica       Date:  2010-07       Impact factor: 9.941

5.  A Prospective, Cross Sectional Study of PNH Clone in MDS Patients Using High Sensitivity Flowcytometry: A Single Center Experience.

Authors:  Faran Naim; Amrita Saraf; Jasmita Dass; Vandana Arya; Sabina Langer; Nitin Gupta; Ajay Sharma; Jyoti Kotwal
Journal:  Indian J Hematol Blood Transfus       Date:  2019-10-24       Impact factor: 0.900

6.  Clonality in context: hematopoietic clones in their marrow environment.

Authors:  James N Cooper; Neal S Young
Journal:  Blood       Date:  2017-10-18       Impact factor: 22.113

7.  Paroxysmal nocturnal haemoglobinuria, diagnosis and haematological findings, first report from Iran, model for developing countries.

Authors:  Mohammadali Jahangirpour; Amirali Vahedi; Hamed Baghdadi; Tahereh Madani; Ali Behvarmanesh; Mohammad Alidadi; Mohadese Hashem Boroojerdi; Saba Mohammaei; Peyvand Poopak; Amirhossein Poopak; Gelareh Khosravi Pour; Behzad Poopak
Journal:  EJHaem       Date:  2022-03-08

8.  Frequency of paroxysmal nocturnal hemoglobinuria in patients attended in Belém, Pará, Brazil.

Authors:  Lacy Cardoso de Brito Junior; Maria do Socorro de Oliveira Cardoso; Euzamar Gaby Rocha; Herika Anijar; Mariana Cunha; João Carlos Pina Saraiva
Journal:  Rev Bras Hematol Hemoter       Date:  2011

9.  Long Standing Eculizumab Treatment without Anticoagulant Therapy in High-Risk Thrombogenic Paroxysmal Nocturnal Hemoglobinuria.

Authors:  Hassan A Al-Jafar; Salma M AlDallal; Haifa A Askar; Ali M Aljeraiwi; Ahmad Al-Alansari
Journal:  Hematol Rep       Date:  2015-09-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.